Forschungsdatenbank PMU-SQQUID

NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F;
STRAHLENTHER ONKOL. 2007; 183 Spec No 2: 38-40.
Originalarbeiten (Zeitschrift)

Abstract/Keywords Web of Science PubMed Full Text

PMU-Autor/inn/en

Deutschmann Heinz
Sedlmayer Felix
Studnicka Michael
Wurstbauer Karl

Useful keywords (using NLM MeSH Indexing)

Actuarial Analysis

Adult

Aged

Aged, 80 and over

Antineoplastic Agents/administration*

dosage

Antineoplastic Agents/therapeutic use

Carboplatin/administration*

dosage

Carboplatin/therapeutic use

Carcinoma, Non-Small-Cell Lung/drug therapy*

Carcinoma, Non-Small-Cell Lung/mortality

Carcinoma, Non-Small-Cell Lung/pathology

Carcinoma, Non-Small-Cell Lung/radiotherapy*

Cisplatin/administration*

dosage

Cisplatin/therapeutic use

Combined Modality Therapy

Female

Follow-Up Studies

Humans

Lung/pathology

Lung Neoplasms/drug therapy

Lung Neoplasms/mortality

Lung Neoplasms/pathology

Lung Neoplasms/radiotherapy*

Male

Middle Aged

Neoplasm Staging

Prospective Studies

Radiation-Sensitizing Agents/administration*

dosage

Radiation-Sensitizing Agents/therapeutic use

Radiotherapy Dosage

Radiotherapy, Conformal*

Randomized Controlled Trials as Topic

Time Factors

Find related publications in this database (Keywords)

lung cancer
non-small cell lung cancer
target splitting
conformal radiotherapy
accelerated radiotherapy